Literature DB >> 7511892

Expression of fibroblast growth factor gene family and its receptor gene family in the human upper gastrointestinal tract.

S Iida1, O Katoh, A Tokunaga, M Terada.   

Abstract

All of 13 human esophageal cancer cell lines contained mRNAs for both basic fibroblast growth factor (bFGF) and its receptor, FGFR1/N-sam protein, while they did not have mRNAs for keratinocyte growth factor (KGF) despite the presence of mRNAs for the KGF receptor gene, K-sam. The results indicate that in human esophageal cancer, bFGF plays roles in an autocrine manner, while KGF acts as a paracrine mediator. In contrast, only one of seven human gastric cancer cell lines contained bFGF mRNAs, while three out of the seven had mRNAs for FGFR1/N-sam protein. The KGF gene was not expressed in any of the gastric cancer cell lines, while K-sam mRNAs were detected in six out of the seven. The results demonstrate that in most human gastric cancers, bFGF does not act as an autocrine mediator, while KGF acts as a paracrine factor. The mRNAs for the other four members of the fibroblast growth factor (FGF) family, including acidic FGF, int-2 protein, hst-1 protein, FGF5 protein and FGF6/hst-2 protein could not be detected in the esophageal and gastric cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511892     DOI: 10.1006/bbrc.1994.1346

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.

Authors:  Austin M Dulak; Steven E Schumacher; Jasper van Lieshout; Yu Imamura; Cameron Fox; Byoungyong Shim; Alex H Ramos; Gordon Saksena; Sylvan C Baca; Jose Baselga; Josep Tabernero; Jordi Barretina; Peter C Enzinger; Giovanni Corso; Franco Roviello; Lin Lin; Santhoshi Bandla; James D Luketich; Arjun Pennathur; Matthew Meyerson; Shuji Ogino; Ramesh A Shivdasani; David G Beer; Tony E Godfrey; Rameen Beroukhim; Adam J Bass
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

2.  A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation.

Authors:  H Ishii; T Yoshida; H Oh; S Yoshida; M Terada
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

3.  Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor.

Authors:  J A Uría; M Balbín; J M López; J Alvarez; F Vizoso; M Takigawa; C López-Otín
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

4.  Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance.

Authors:  C Yiangou; J J Gomm; R C Coope; M Law; Y A Luqmani; S Shousha; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases.

Authors:  D G Jayne; S L Perry; E Morrison; S M Farmery; P J Guillou
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

6.  FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.

Authors:  Jun Iwabu; Satoshi Yamashita; Hideyuki Takeshima; Takayoshi Kishino; Takamasa Takahashi; Ichiro Oda; Kazuo Koyanagi; Hiroyasu Igaki; Yuji Tachimori; Hiroyuki Daiko; Hidetsugu Nakazato; Kazuhiro Nishiyama; Yi-Chia Lee; Kazuhiro Hanazaki; Toshikazu Ushijima
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.